Madrigal Pharmaceuticals inc. buy melinda
Start price
23.10.17
/
50%
€40.66
Target price
01.11.17
€49.61
Performance (%)
10.91%
End price
01.11.17
€45.10
Summary
This prediction ended on 01.11.17 with a price of €45.10. The BUY prediction by melinda finished with a performance of 10.91%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Madrigal Pharmaceuticals inc. | -1.816% | -1.816% | 67.620% | 784.727% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by melinda for this prediction
In the thread Madrigal Pharmaceuticals inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
Madrigal Pharmaceuticals präsentiert präklinische das therapeutische Potential der Agonist rezeptorselektiven β-selektive Thyroidhormon, SW-3196, bei dem Treffen der Leber AASLD unterstützen
Die Ergebnisse zeigen , dass MGL-3196 metabolische Vorteile bieten, entzündungshemmende und anti-fibrotische in einer langfristigen Ernährung reich an Fett, NASH Mäuse
(Vom Mitglied beendet)
Stopped prediction by melinda for Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€96.54
23.11.20
23.11.20
€108.00
23.11.21
23.11.21
-25.42%
24.11.21
24.11.21
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€124.73
26.02.18
26.02.18
€135.30
31.05.18
31.05.18
56.77%
31.05.18
31.05.18
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€73.53
06.12.17
06.12.17
€90.20
29.12.17
29.12.17
14.44%
29.12.17
29.12.17
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€170.38
26.09.13
26.09.13
€210.00
26.03.14
26.03.14
-34.33%
26.03.14
26.03.14
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€156.52
06.06.12
06.06.12
€175.00
06.12.12
06.12.12
27.93%
06.12.12
06.12.12